Merck (MRK.N) has entered a licensing agreement worth up to $2 billion with Chinese biotech firm Hansoh Pharma (3692.HK) for the development of an experimental oral...
Etiket: Drug Development
GSK’s Linerixibat Shows Success in Treating Relentless Itch in Late-Stage Trial
Breakthrough in Itch Treatment for Autoimmune Disease GSK (GlaxoSmithKline) announced on Tuesday that its experimental drug, linerixibat, successfully met its primary endpoint in a late-stage trial...